Form D · Other
Spearbit Labs Inc.
New York, NY · CIK 0001899952
Offering snapshot reported Oct 14, 2025 · SEC filing
- Reported sold
- $7.83M Offering amount: $8M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 1, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 14, 2025 | Initial | $7,826,037 | No comparison | 3 | SEC filing |
| Jul 13, 2023 | Amendment | $8,266,983 | $1,500,000vs Jul 12, 2023 | 20 | SEC filing |
| Jul 12, 2023 | Initial | $6,766,983 | No comparison | 8 | SEC filing |
| Dec 17, 2021 | Initial | $1,500,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-560669
Source: Form D, filed Oct 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Anderson | Director |
| Max Abel Goodman | Director |
| Jake Lang | Director, Executive |
| Mike Leffer | Executive |
| Spencer Macdonald | Director, Executive |
| Harikrishnan Mulackal | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
135 Madison Ave
New York, NY, 10016
New York, NY, 10016